MedPath

Prospective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children

Not Applicable
Completed
Conditions
Pediatric Brain Stem Glioma
Interventions
Radiation: Hypofractionated Arm (2)
Radiation: Hypofractionated Arm (1)
Radiation: Conventional Arm (3)
Registration Number
NCT01878266
Lead Sponsor
Children's Cancer Hospital Egypt 57357
Brief Summary

This Trial offers a reduction in patient burden, which is especially preferable in children with a poor compliance and poor performance status. This prospective randomized trial was extension to the previous controlled prospective study performed in Children's Cancer Hospital, Egypt and registered at clinicaltrials.com (NCT01635140). The ultimate aim of this work is to demonstrate noninferiority of the hypofractionated regimens relative to the conventional regimen in a controlled randomized clinical study.

Detailed Description

In this study will add a third arm in which we will increase in the total dose to 4500 cGy in 15 fractions in 3 weeks may lead to improvement in Over-all survival or Progression-Free Survival.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
119
Inclusion Criteria
  1. Newly diagnosed patients with a diffuse intrinsic brainstem glioma
  2. Aged 2-18years,
  3. Have symptoms for less than 3 months and at least two findings of the neurologic triad: cranial nerve deficits, ataxia, or long tract signs.
  4. No performance criteria were required for entry onto the study.
Exclusion Criteria
  • Children were not eligible if they had received any prior therapy other than steroids Treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Hypofractionated Arm (2)Hypofractionated Arm (2)The same planning and treatment procedures will be performed. The total dose will be 4500 cGy in 15 fractions in 3 weeks; giving 300 cGy per fraction.
Hypofractionated Arm (1)Hypofractionated Arm (1)A total dose of 39 Gy in daily fractions of 3 Gy, 5 Fractions per week , by conformal radiotherapy sparing of the supratentorial brain. The planning target volume included the tumor as defined by the T2-weighted MRI images with a margin of 1.5-2.0 cm. Margins were adjusted for bony structures and tentorium. With exception of steroids, no neoadjuvant, concomitant, or adjuvant systemic treatment was allowed
Conventional Arm (3)Conventional Arm (3)The same planning and treatment procedures will be performed with 54.0 Gy in 30 fractions giving 1.8 Gy per fraction.
Primary Outcome Measures
NameTimeMethod
Median overall-free survival3 years
Secondary Outcome Measures
NameTimeMethod
Progression-free survival3 years

Trial Locations

Locations (1)

Children's Cancer Hospital Egypt 57357

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath